Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi

• Main Authors: Chenggang Xu (Author), Le Tang (Author), Lixin Hu (Author), Yunzhe Huang (Author), Jin Tang (Author), Xiaohu Wang (Author), Feng Wang (Author)
• Format: Book
• Published: Hindawi-Wiley, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Modern pharmacological studies have elucidated the presence of aconitine (AC) alkaloids, polysaccharides, and saponins as the primary bioactive constituents of Fuzi. Among these, benzoylaconine, a pivotal active compound, demonstrates notable pharmacological properties including antitumor, anti-infl...